Global Real-Time PCR Assays Market Insights, Forecast to 2028

Market Analysis and Insights: Global Real-Time PCR Assays Market
Due to the COVID-19 pandemic, the global Real-Time PCR Assays market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Relative Quantification accounting for % of the Real-Time PCR Assays global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While PCR segment is altered to an % CAGR throughout this forecast period.
China Real-Time PCR Assays market size is valued at US$ million in 2021, while the US and Europe Real-Time PCR Assays are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Real-Time PCR Assays landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Real-Time PCR Assays include Roche, BLIRT, Qiagen, Merck, Ampliqon, Applied Biosystems, Bio-Rad, Takara Bio and Illumina, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Real-Time PCR Assays Scope and Segment
Real-Time PCR Assays market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Real-Time PCR Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Relative Quantification
Absolute Quantification
Segment by Application
PCR
RT-PCR
By Company
Roche
BLIRT
Qiagen
Merck
Ampliqon
Applied Biosystems
Bio-Rad
Takara Bio
Illumina
Thermo Fisher Scientific
Promega
New England Biolabs
Bioneer
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE